Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
CAMBRIDGE, Mass., Dec. 24, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the expansion of its integrated discovery and development...
Global Times: China's economic potential reflected in auto sector's 'three 30-million' milestones
BEIJING, Dec. 24, 2025 /PRNewswire/ -- A video released on Sunday by studio Yishijie offered an explanation of a recent People's Daily article, stressing that China's economy is "large not only in scale, but also in potential," and expressing strong...
SI Group Announces Closing of Comprehensive Recapitalization, Positioning the Company for Accelerated Growth
Significant De-leveraging Transaction Resulting in Overall Debt Reduction of Approximately $1.7 Billion THE WOODLANDS, Texas, Dec. 24, 2025 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process...
CodiMe Expands Overseas Business with AI Fashion Image SaaS "Potoo," Targeting Japan as a Key Market
SEOUL, South Korea, Dec. 24, 2025 /PRNewswire/ -- CodiMe Co., Ltd., a fashion AI startup, said it is accelerating its overseas business expansion in 2025, with Japan positioned as a key strategic market for its AI fashion image generation...
Gallery360 to Expand VR Exhibition Platform Globally in 2025, with Japan as a Focus Market
SEOUL, South Korea, Dec. 24, 2025 /PRNewswire/ -- Gallery360, a South Korea–based smart art platform company, said it will accelerate the global expansion of its VR exhibition platform in 2025, with Japan positioned as a key market alongside...
NSF Retail Food Safety Audits Launch in Thailand with Nadimos Lebanese Restaurant as First Site to Achieve Compliance
Verified food retailers and restaurants demonstrate a strong commitment to hygiene, food safety and regulatory compliance BANGKOK, Dec. 24, 2025 /PRNewswire/ -- NSF, a leading global public health and safety organization, today announced that...
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Gastric Cancer.
SEONGNAM, South Korea, Dec. 24, 2025 /PRNewswire/ -- SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (including gastroesophageal junction cancer) to SNB-101...
From Discoverative AI to the Entropy of Tolerance: Tianqiao Chen's Vision of Human-AI Co-Evolution
SAN MATEO, Calif., Dec. 24, 2025 /PRNewswire/ -- Shanda Group has entered a period of renewed visibility, with a series of incubated ventures coming to light over the past several months. At the center of this momentum is its founder, Tianqiao Chen,...